Correction: Bone morphogenetic protein-7 is a MYC target with prosurvival functions in childhood medulloblastoma (Oncogene, (2011), 30, 25, (2823-2835), 10.1038/onc.2011.10)

G. Fiaschetti; D. Castelletti; S. Zoller; A. Schramm; C. Schroeder; M. Nagaishi; D. Stearns; M. Mittelbronn; A. Eggert; F. Westermann; H. Ohgaki; T. Shalaby; M. Pruschy; A. Arcaro; M. A. Grotzer

doi:10.1038/s41388-022-02555-9

Correction: Bone morphogenetic protein-7 is a MYC target with prosurvival functions in childhood medulloblastoma (Oncogene, (2011), 30, 25, (2823-2835), 10.1038/onc.2011.10)

G. Fiaschetti, D. Castelletti, S. Zoller, A. Schramm, C. Schroeder, M. Nagaishi, D. Stearns, M. Mittelbronn, A. Eggert, F. Westermann, H. Ohgaki, T. Shalaby, M. Pruschy, A. Arcaro, M. A. Grotzer^*

^*Corresponding author for this work

Research output: Contribution to journal › Comment/debate

Abstract

Following publication of this article, the authors noted Figure 1b incorrectly reported beta-tubulin as the control used for the western blot analysis when beta-actin was used. In addition, in this figure, the control bands of DAOY cells M2.1 and M14 were inadvertently swapped. The corrected figure is shown below. The authors apologise for the inconvenience caused and confirm this does not have any impact on the interpretation of the results. The original article has been corrected.

Original language	English
Pages (from-to)	168
Number of pages	1
Journal	Oncogene
Volume	42
Issue number	2
Early online date	7 Dec 2022
DOIs	https://doi.org/10.1038/s41388-022-02555-9
Publication status	Published - Jan 2023
Externally published	Yes

Access to Document

10.1038/s41388-022-02555-9

Cite this

Fiaschetti, G., Castelletti, D., Zoller, S., Schramm, A., Schroeder, C., Nagaishi, M., Stearns, D., Mittelbronn, M., Eggert, A., Westermann, F., Ohgaki, H., Shalaby, T., Pruschy, M., Arcaro, A., & Grotzer, M. A. (2023). Correction: Bone morphogenetic protein-7 is a MYC target with prosurvival functions in childhood medulloblastoma (Oncogene, (2011), 30, 25, (2823-2835), 10.1038/onc.2011.10). Oncogene, 42(2), 168. https://doi.org/10.1038/s41388-022-02555-9

@article{55fc267090ff4078bc83fe0d7130a984,

title = "Correction: Bone morphogenetic protein-7 is a MYC target with prosurvival functions in childhood medulloblastoma (Oncogene, (2011), 30, 25, (2823-2835), 10.1038/onc.2011.10)",

abstract = "Following publication of this article, the authors noted Figure 1b incorrectly reported beta-tubulin as the control used for the western blot analysis when beta-actin was used. In addition, in this figure, the control bands of DAOY cells M2.1 and M14 were inadvertently swapped. The corrected figure is shown below. The authors apologise for the inconvenience caused and confirm this does not have any impact on the interpretation of the results. The original article has been corrected.",

author = "G. Fiaschetti and D. Castelletti and S. Zoller and A. Schramm and C. Schroeder and M. Nagaishi and D. Stearns and M. Mittelbronn and A. Eggert and F. Westermann and H. Ohgaki and T. Shalaby and M. Pruschy and A. Arcaro and Grotzer, {M. A.}",

note = "Publisher Copyright: {\textcopyright} 2022, The Author(s), under exclusive licence to Springer Nature Limited.",

year = "2023",

month = jan,

doi = "10.1038/s41388-022-02555-9",

language = "English",

volume = "42",

pages = "168",

journal = "Oncogene",

issn = "0950-9232",

publisher = "Springer Nature",

number = "2",

}

Fiaschetti, G, Castelletti, D, Zoller, S, Schramm, A, Schroeder, C, Nagaishi, M, Stearns, D, Mittelbronn, M, Eggert, A, Westermann, F, Ohgaki, H, Shalaby, T, Pruschy, M, Arcaro, A & Grotzer, MA 2023, 'Correction: Bone morphogenetic protein-7 is a MYC target with prosurvival functions in childhood medulloblastoma (Oncogene, (2011), 30, 25, (2823-2835), 10.1038/onc.2011.10)', Oncogene, vol. 42, no. 2, pp. 168. https://doi.org/10.1038/s41388-022-02555-9

TY - JOUR

T1 - Correction

T2 - Bone morphogenetic protein-7 is a MYC target with prosurvival functions in childhood medulloblastoma (Oncogene, (2011), 30, 25, (2823-2835), 10.1038/onc.2011.10)

AU - Fiaschetti, G.

AU - Castelletti, D.

AU - Zoller, S.

AU - Schramm, A.

AU - Schroeder, C.

AU - Nagaishi, M.

AU - Stearns, D.

AU - Mittelbronn, M.

AU - Eggert, A.

AU - Westermann, F.

AU - Ohgaki, H.

AU - Shalaby, T.

AU - Pruschy, M.

AU - Arcaro, A.

AU - Grotzer, M. A.

PY - 2023/1

Y1 - 2023/1

N2 - Following publication of this article, the authors noted Figure 1b incorrectly reported beta-tubulin as the control used for the western blot analysis when beta-actin was used. In addition, in this figure, the control bands of DAOY cells M2.1 and M14 were inadvertently swapped. The corrected figure is shown below. The authors apologise for the inconvenience caused and confirm this does not have any impact on the interpretation of the results. The original article has been corrected.

AB - Following publication of this article, the authors noted Figure 1b incorrectly reported beta-tubulin as the control used for the western blot analysis when beta-actin was used. In addition, in this figure, the control bands of DAOY cells M2.1 and M14 were inadvertently swapped. The corrected figure is shown below. The authors apologise for the inconvenience caused and confirm this does not have any impact on the interpretation of the results. The original article has been corrected.

UR - http://www.scopus.com/inward/record.url?scp=85143724863&partnerID=8YFLogxK

UR - https://pubmed.ncbi.nlm.nih.gov/36476835

U2 - 10.1038/s41388-022-02555-9

DO - 10.1038/s41388-022-02555-9

M3 - Comment/debate

C2 - 36476835

AN - SCOPUS:85143724863

SN - 0950-9232

VL - 42

SP - 168

JO - Oncogene

JF - Oncogene

IS - 2

ER -

Correction: Bone morphogenetic protein-7 is a MYC target with prosurvival functions in childhood medulloblastoma (Oncogene, (2011), 30, 25, (2823-2835), 10.1038/onc.2011.10)

Abstract

Access to Document

Other files and links

Fingerprint

Cite this